• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Role of von Willebrand Factor and ADAMTS-13 in the Pathogenesis of Thrombi in SARS-CoV-2 Infection: Time to Rethink.

作者信息

Morici Nuccia, Bottiroli Maurizio, Fumagalli Roberto, Marini Claudia, Cattaneo Marco

机构信息

Intensive Cardiac Care Unit and De Gasperis Cardio Center, ASST Grande Ospedale Metropolitano Niguarda, Milan, Italy.

Department of Clinical Sciences and Community Health, Università degli Studi di Milano, Milan, Italy.

出版信息

Thromb Haemost. 2020 Sep;120(9):1339-1342. doi: 10.1055/s-0040-1713400. Epub 2020 Jun 23.

DOI:10.1055/s-0040-1713400
PMID:32575136
Abstract
摘要

相似文献

1
Role of von Willebrand Factor and ADAMTS-13 in the Pathogenesis of Thrombi in SARS-CoV-2 Infection: Time to Rethink.血管性血友病因子和ADAMTS-13在新型冠状病毒感染血栓形成发病机制中的作用：是时候重新思考了。
Thromb Haemost. 2020 Sep;120(9):1339-1342. doi: 10.1055/s-0040-1713400. Epub 2020 Jun 23.
2
[The effects of activated protein C on the von Willebrand factor and von Willebrand factor cleaving protease of rat aortic endothelial cell induced by lipopolysaccharide].[活化蛋白C对脂多糖诱导的大鼠主动脉内皮细胞血管性血友病因子及血管性血友病因子裂解蛋白酶的影响]
Zhongguo Wei Zhong Bing Ji Jiu Yi Xue. 2012 Aug;24(8):487-9.
3
Pathologic von Willebrand factor degradation with a left ventricular assist device occurs via two distinct mechanisms: mechanical demolition and enzymatic cleavage.左心室辅助装置导致病理性血管性血友病因子降解是通过两种不同的机制发生的：机械破坏和酶切。
J Thorac Cardiovasc Surg. 2015 Jan;149(1):281-9. doi: 10.1016/j.jtcvs.2014.09.031. Epub 2014 Sep 18.
4
Changes in von Willebrand factor-cleaving protease (ADAMTS-13) in patients with aortic stenosis undergoing valve replacement or balloon valvuloplasty.主动脉瓣狭窄患者行瓣膜置换术或球囊瓣膜成形术前后 von Willebrand 因子裂解蛋白酶（ADAMTS-13）的变化。
Thromb Haemost. 2012 Jul;108(1):86-93. doi: 10.1160/TH11-12-0803. Epub 2012 May 25.
5
ADAMTS-13 attenuates thrombus formation on type I collagen surface and disrupted plaques under flow conditions.ADAMTS-13可减弱在I型胶原表面的血栓形成，并在流动条件下破坏斑块。
Atherosclerosis. 2009 Apr;203(2):409-16. doi: 10.1016/j.atherosclerosis.2008.07.043. Epub 2008 Aug 13.
6
von Willebrand factor cleaving protease (ADAMTS-13) and ADAMTS-13 neutralizing autoantibodies in 100 patients with thrombotic thrombocytopenic purpura.100例血栓性血小板减少性紫癜患者的血管性血友病因子裂解蛋白酶（ADAMTS - 13）及ADAMTS - 13中和性自身抗体
Br J Haematol. 2004 Nov;127(4):433-9. doi: 10.1111/j.1365-2141.2004.05217.x.
7
Change in plasma a disintegrin and metalloprotease with thrombospondin type-1 repeats-13 and von Willebrand factor levels in venous thromboembolic patients.静脉血栓栓塞患者血浆中含Ⅰ型血小板反应蛋白基序的解聚素和金属蛋白酶-13及血管性血友病因子水平的变化
Hematology. 2016 Jun;21(5):295-9. doi: 10.1080/10245332.2015.1125079. Epub 2016 Feb 16.
8
Beneficial Effects of High-Density Lipoproteins on Acquired von Willebrand Syndrome in Aortic Valve Stenosis.高密度脂蛋白对主动脉瓣狭窄获得性血管性血友病综合征的有益作用。
Thromb Haemost. 2018 Feb;118(2):288-297. doi: 10.1160/TH17-10-0729. Epub 2018 Jan 29.
9
Plasma levels of von Willebrand factor regulate ADAMTS-13, its major cleaving protease.血管性血友病因子的血浆水平调节其主要裂解蛋白酶ADAMTS-13。
Br J Haematol. 2004 Jul;126(2):213-8. doi: 10.1111/j.1365-2141.2004.05009.x.
10
Evaluation of von Willebrand factor and ADAMTS-13 antigen and activity levels in sickle cell disease patients in Kuwait.科威特镰状细胞病患者血管性血友病因子及ADAMTS-13抗原和活性水平的评估
J Thromb Thrombolysis. 2017 Jan;43(1):117-123. doi: 10.1007/s11239-016-1418-4.

引用本文的文献

1
SARS-CoV-2 mechanisms of cell tropism in various organs considering host factors.考虑宿主因素的SARS-CoV-2在各器官中的细胞嗜性机制。
Heliyon. 2024 Feb 20;10(4):e26577. doi: 10.1016/j.heliyon.2024.e26577. eCollection 2024 Feb 29.
2
Endotheliopathy in Acute COVID-19 and Long COVID.急性 COVID-19 和长新冠中的血管内皮病。
Int J Mol Sci. 2023 May 4;24(9):8237. doi: 10.3390/ijms24098237.
3
Pharmacotherapy consideration of thrombolytic medications in COVID-19-associated ARDS.新型冠状病毒肺炎相关急性呼吸窘迫综合征中溶栓药物的药物治疗考量
J Intensive Care. 2022 Jul 30;10(1):38. doi: 10.1186/s40560-022-00625-4.
4
Adamalysins in COVID-19 - Potential mechanisms behind exacerbating the disease.COVID-19 中的 Adamalysins - 加重疾病的潜在机制。
Biomed Pharmacother. 2022 Jun;150:112970. doi: 10.1016/j.biopha.2022.112970. Epub 2022 Apr 15.
5
Peripheral neurological complications during COVID-19: A single center experience.COVID-19 相关外周神经系统并发症：单中心经验。
J Neurol Sci. 2022 Mar 15;434:120118. doi: 10.1016/j.jns.2021.120118. Epub 2021 Dec 23.
6
High levels of Von Willebrand factor markers in COVID-19: a systematic review and meta-analysis.COVID-19 中高水平的血管性血友病因子标志物：一项系统评价和荟萃分析。
Clin Exp Med. 2022 Aug;22(3):347-357. doi: 10.1007/s10238-021-00769-x. Epub 2021 Nov 6.
7
Age-Associated Increase in Thrombogenicity and Its Correlation with von Willebrand Factor.与年龄相关的血栓形成倾向增加及其与血管性血友病因子的相关性。
J Clin Med. 2021 Sep 16;10(18):4190. doi: 10.3390/jcm10184190.
8
Von Willebrand factor: A key glycoprotein involved in thrombo-inflammatory complications of COVID-19.血管性血友病因子：一种与 COVID-19 血栓炎症并发症相关的关键糖蛋白。
Chem Biol Interact. 2021 Oct 1;348:109657. doi: 10.1016/j.cbi.2021.109657. Epub 2021 Sep 10.
9
Cardiovascular injuries and SARS-COV-2 infection: focus on elderly people.心血管损伤与新型冠状病毒肺炎感染：关注老年人
J Geriatr Cardiol. 2021 Jul 28;18(7):534-548. doi: 10.11909/j.issn.1671-5411.2021.07.001.
10
COVID-19 and biomarkers of thrombosis: focus on von Willebrand factor and extracellular vesicles.2019冠状病毒病与血栓形成的生物标志物：聚焦于血管性血友病因子和细胞外囊泡
J Thromb Thrombolysis. 2021 Nov;52(4):1010-1019. doi: 10.1007/s11239-021-02544-x. Epub 2021 Aug 4.